EUVIMEDEUVIMED entdecken
Crossref

Does the Patent Linkage System Prolong Effective Market Exclusivity? Recent Evidence From the Korea-U.S. Free Trade Agreement in Korea

Kyung-Bok Son iD, SeungJin Bae, Tae-Jin Lee

International Journal of Health Services · 2019-04 · 49 (2) · 306-321

DOI: 10.1177/0020731418822237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Health Services, online erschienen am 09.01.2019. Verfasst von Kyung-Bok Son und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1 College of Pharmacy, Ewha Womans University, Seoul, South Korea. Hauptthemen laut MEDLINE: International Cooperation, Legislation, Drug, Patents as Topic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluated the effect of the patent linkage system, fully introduced by the Korea-U.S. Free Trade Agreement in 2015, on patent challenges and the effective market exclusivity of new medicines in Korea. We used pharmaceutical approval data and pharmaceutical litigation data to detect new medicines and their counterparts, to collect patent challenges against new medicines, and to calculate effective market exclusivity for new medicines. Then, a nonparametric event history model was applied to statistically explain the duration of the market exclusivity of new medicines. Between 2007 and 2011, a total of 94 new medicines, consisting of 82 new chemical entities and 12 new biologics, were approved. The patent linkage system encouraged patent litigations to occur sooner, with a race to challenge the patents by various generic applicants. However, it was difficult to conclude that patent challenges had a significant impact on the prolongation of effective market exclusivity. The patent linkage system had a neutral effect on the effective market exclusivity of new medicines and encouraged patent challenges without abbreviating effective market exclusivity. In addition, this study highlights an important issue regarding biologics that has not been the subject of market competition, even for patent challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

International CooperationLegislation, DrugPatents as TopicDrug ApprovalHumansInternationalityMarketingRepublic of KoreaUnited States

Stichwörter der Autor:innen

free trade agreementslinkagemarket exclusivitypatent challengepatent linkage

Autor:innen und Institutionen

  • 1 College of Pharmacy, Ewha Womans University, Seoul, South Korea.
  • 2 Institute of Health and Environment, Seoul National University, Seoul, South Korea.
  • 3 Department of Public Health Science, Graduate School of Public Health, Seoul National University, Seoul, South Korea.

ORCID-Profile: Kyung-Bok Son

Zitieren

APA

Son, K. B., Bae, S., & Lee, T. J. (2019). Does the Patent Linkage System Prolong Effective Market Exclusivity? Recent Evidence From the Korea-U.S. Free Trade Agreement in Korea. International Journal of Health Services, 49(2), 306-321. https://doi.org/10.1177/0020731418822237

Vancouver

Son KB, Bae S, Lee TJ. Does the Patent Linkage System Prolong Effective Market Exclusivity? Recent Evidence From the Korea-U.S. Free Trade Agreement in Korea. International Journal of Health Services. 2019;49(2):306-321. doi:10.1177/0020731418822237

BibTeX
@article{Son2019,
  author = {Son, Kyung-Bok and Bae, SeungJin and Lee, Tae-Jin},
  title = {Does the Patent Linkage System Prolong Effective Market Exclusivity? Recent Evidence From the Korea-U.S. Free Trade Agreement in Korea},
  journal = {International Journal of Health Services},
  year = {2019},
  volume = {49},
  number = {2},
  pages = {306--321},
  doi = {10.1177/0020731418822237}
}
Kostenlos starten →